These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23223585)

  • 21. Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control.
    Romanelli RM; Jesus LA; Clemente WT; Lima SS; Rezende EM; Coutinho RL; Moreira RL; Neves FA; Brás Nde J
    Braz J Infect Dis; 2009 Oct; 13(5):341-7. PubMed ID: 20428632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of Acinetobacter baumannii carriage in patients of 53 French intensive care units on a given day].
    Chatellier D; Burucoa C; Pinsard M; Frat JP; Robert R
    Med Mal Infect; 2007 Feb; 37(2):112-7. PubMed ID: 17258416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Acinetobacter baumannii genotypes recovered from patients with repeated colonization or infection.
    Qi C; Scheetz MH; Malczynski M
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):1-6. PubMed ID: 19679228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.
    Akers KS; Barsoumian A; Beckius ML; Murray CK; Mende K
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):209-11. PubMed ID: 20466197
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Swab cultures across three different body sites among carriers of carbapenem-resistant P. aeruginosa and Acinetobacter species: a poor surveillance strategy.
    Dalben MF; Oliveira MS; Garcia CP; Lobo RD; Costa SF; Toscano CM; Levin AS
    J Hosp Infect; 2010 Apr; 74(4):395-6. PubMed ID: 19717211
    [No Abstract]   [Full Text] [Related]  

  • 28. Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital.
    Cristina ML; Spagnolo AM; Ottria G; Sartini M; Orlando P; Perdelli F;
    Am J Infect Control; 2011 Nov; 39(9):790-4. PubMed ID: 21704428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
    Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K
    Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
    Cui JC; Liu YN; Chen LA
    J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
    [No Abstract]   [Full Text] [Related]  

  • 31. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.
    Shields RK; Kwak EJ; Potoski BA; Doi Y; Adams-Haduch JM; Silviera FP; Toyoda Y; Pilewski JM; Crespo M; Pasculle AW; Clancy CJ; Nguyen MH
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endemic carbapenem-resistant Acinetobacter baumannii in a London hospital.
    Manuel RJ; Shin GY; Farrag N; Holliman R
    J Antimicrob Chemother; 2003 Jul; 52(1):141-2. PubMed ID: 12775679
    [No Abstract]   [Full Text] [Related]  

  • 34. Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal.
    Diene SM; Fall B; Kempf M; Fenollar F; Sow K; Niang B; Wade B; Raoult D; Rolain JM
    Int J Infect Dis; 2013 Mar; 17(3):e209-10. PubMed ID: 23084970
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates.
    Kiratisin P; Apisarnthanarak A; Kaewdaeng S
    Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.
    del Mar Tomas M; Cartelle M; Pertega S; Beceiro A; Llinares P; Canle D; Molina F; Villanueva R; Cisneros JM; Bou G
    Clin Microbiol Infect; 2005 Jul; 11(7):540-6. PubMed ID: 15966971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan.
    Irfan S; Turton JF; Mehraj J; Siddiqui SZ; Haider S; Zafar A; Memon B; Afzal O; Hasan R
    J Hosp Infect; 2011 Jun; 78(2):143-8. PubMed ID: 21459477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.
    Lu PL; Huang LY; Lian ST; Chang K; Lin CL; Hwang IJ; Chiang WG; Chen YH; Lin SF; Siu LK
    Int J Antimicrob Agents; 2008 May; 31(5):463-6. PubMed ID: 18359613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acinetobacter baumannii resistant to everything: what should we do?
    Vila J; Pachón J
    Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
    [No Abstract]   [Full Text] [Related]  

  • 40. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain.
    Mugnier PD; Bindayna KM; Poirel L; Nordmann P
    J Antimicrob Chemother; 2009 May; 63(5):1071-3. PubMed ID: 19252183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.